195 related articles for article (PubMed ID: 25913477)
1. Perturbation of the intestinal microbiota of mice infected with Cryptosporidium parvum.
Ras R; Huynh K; Desoky E; Badawy A; Widmer G
Int J Parasitol; 2015 Jul; 45(8):567-73. PubMed ID: 25913477
[TBL] [Abstract][Full Text] [Related]
2. Neonatal Mouse Gut Metabolites Influence Cryptosporidium parvum Infection in Intestinal Epithelial Cells.
VanDussen KL; Funkhouser-Jones LJ; Akey ME; Schaefer DA; Ackman K; Riggs MW; Stappenbeck TS; Sibley LD
mBio; 2020 Dec; 11(6):. PubMed ID: 33323514
[TBL] [Abstract][Full Text] [Related]
3. Cryptosporidium parvum-Infected Neonatal Mice Show Gut Microbiota Remodelling Using High-Throughput Sequencing Analysis: Preliminary Results.
Mammeri M; Chevillot A; Thomas M; Julien C; Auclair E; Pollet T; Polack B; Vallée I; Adjou KT
Acta Parasitol; 2019 Jun; 64(2):268-275. PubMed ID: 30915719
[TBL] [Abstract][Full Text] [Related]
4. Probiotic Product Enhances Susceptibility of Mice to Cryptosporidiosis.
Oliveira BCM; Widmer G
Appl Environ Microbiol; 2018 Nov; 84(21):. PubMed ID: 30171003
[TBL] [Abstract][Full Text] [Related]
5. Specific increase of Fusobacterium in the faecal microbiota of neonatal calves infected with Cryptosporidium parvum.
Ichikawa-Seki M; Motooka D; Kinami A; Murakoshi F; Takahashi Y; Aita J; Hayashi K; Tashibu A; Nakamura S; Iida T; Horii T; Nishikawa Y
Sci Rep; 2019 Aug; 9(1):12517. PubMed ID: 31467354
[TBL] [Abstract][Full Text] [Related]
6. Case Report: The impact of severe cryptosporidiosis on the gut microbiota of a pediatric patient with CD40L immunodeficiency.
Piazzesi A; Pane S; Russo A; Del Chierico F; Francalanci P; Cotugno N; Rossi P; Locatelli F; Palma P; Putignani L
Front Cell Infect Microbiol; 2023; 13():1281440. PubMed ID: 37965266
[No Abstract] [Full Text] [Related]
7. Interaction of Cryptosporidium hominis and Cryptosporidium parvum with primary human and bovine intestinal cells.
Hashim A; Mulcahy G; Bourke B; Clyne M
Infect Immun; 2006 Jan; 74(1):99-107. PubMed ID: 16368962
[TBL] [Abstract][Full Text] [Related]
8. Assessment of Cryptosporidium parvum infection in immunocompetent and immunocompromised mice and its role in triggering intestinal dysplasia.
Abdou AG; Harba NM; Afifi AF; Elnaidany NF
Int J Infect Dis; 2013 Aug; 17(8):e593-600. PubMed ID: 23291034
[TBL] [Abstract][Full Text] [Related]
9. Induction of Inflammatory Responses in Splenocytes by Exosomes Released from Intestinal Epithelial Cells following
Wang Y; Shen Y; Liu H; Yin J; Zhang XT; Gong AY; Chen X; Chen S; Mathy NW; Cao J; Chen XM
Infect Immun; 2019 Apr; 87(4):. PubMed ID: 30642905
[No Abstract] [Full Text] [Related]
10. Curcumin mitigates Cryptosporidium parvum infection through modulation of gut microbiota and innate immune-related genes in immunosuppressed neonatal mice.
Rahman SU; Zhou K; Zhou S; Sun T; Mi R; Huang Y; Han X; Gong H; Chen Z
Microb Pathog; 2022 Mar; 164():105424. PubMed ID: 35092833
[TBL] [Abstract][Full Text] [Related]
11. Deprivation of dietary fiber enhances susceptibility of mice to cryptosporidiosis.
Oliveira BCM; Bresciani KDS; Widmer G
PLoS Negl Trop Dis; 2019 Sep; 13(9):e0007411. PubMed ID: 31560681
[TBL] [Abstract][Full Text] [Related]
12. [Highly Active AntiRetroviral Therapy and cryptosporidiosis].
Morales Gomez MA
Parassitologia; 2004 Jun; 46(1-2):95-9. PubMed ID: 15305695
[TBL] [Abstract][Full Text] [Related]
13. Microbiome diversity is a modifiable virulence factor for cryptosporidiosis.
Hurle GR; Brainard J; Tyler KM
Virulence; 2023 Dec; 14(1):2273004. PubMed ID: 37872759
[No Abstract] [Full Text] [Related]
14. Poly(I:C)-induced protection of neonatal mice against intestinal Cryptosporidium parvum infection requires an additional TLR5 signal provided by the gut flora.
Lantier L; Drouet F; Guesdon W; Mancassola R; Metton C; Lo-Man R; Werts C; Laurent F; Lacroix-Lamandé S
J Infect Dis; 2014 Feb; 209(3):457-67. PubMed ID: 24014881
[TBL] [Abstract][Full Text] [Related]
15. B cells are required for the induction of intestinal inflammatory lesions in TCRalpha-deficient mice persistently infected with Cryptosporidium parvum.
Waters WR; Palmer MV; Wannemuehler MJ; Sacco RE; Harp JA
J Parasitol; 2000 Oct; 86(5):1073-7. PubMed ID: 11128483
[TBL] [Abstract][Full Text] [Related]
16. Host cell tropism underlies species restriction of human and bovine Cryptosporidium parvum genotypes.
Hashim A; Clyne M; Mulcahy G; Akiyoshi D; Chalmers R; Bourke B
Infect Immun; 2004 Oct; 72(10):6125-31. PubMed ID: 15385517
[TBL] [Abstract][Full Text] [Related]
17. Substance P receptor antagonist reverses intestinal pathophysiological alterations occurring in a novel ex-vivo model of Cryptosporidium parvum infection of intestinal tissues derived from SIV-infected macaques.
Garza A; Lackner A; Aye P; D'Souza M; Martin P; Borda J; Tweardy DJ; Weinstock J; Griffiths J; Robinson P
J Med Primatol; 2008 Jun; 37(3):109-15. PubMed ID: 18547256
[TBL] [Abstract][Full Text] [Related]
18. Experimental infection with Cryptosporidium parvum IIaA21G1R1 subtype in immunosuppressed mice.
Del Coco VF; Córdoba MA; Sidoti A; Santín M; Drut R; Basualdo JA
Vet Parasitol; 2012 Dec; 190(3-4):411-7. PubMed ID: 22818787
[TBL] [Abstract][Full Text] [Related]
19. Effects of Cryptosporidium parvum infection on intestinal fungal microbiota in yaks (Bos grunniens).
Lu S; Zou W; Chen X; Sun G; Cidan Y; Almutairi MH; Dunzhu L; Nazar M; Mehmood K; Zhu Y; Basang W; Li K
Microb Pathog; 2023 Oct; 183():106322. PubMed ID: 37633503
[TBL] [Abstract][Full Text] [Related]
20. Treatment with agmatine inhibits Cryptosporidium parvum infection in infant mice.
Moore D; Waters WR; Wannemuehler MJ; Harp JA
J Parasitol; 2001 Feb; 87(1):211-3. PubMed ID: 11227893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
